Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
about
pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.Garcinol sensitizes breast cancer cells to Taxol through the suppression of caspase-3/iPLA2 and NF-κB/Twist1 signaling pathways in a mouse 4T1 breast tumor model.Dual nanoparticle drug delivery: the future of anticancer therapies?Physicochemical characterization of drug nanocarriers.Trans-scirpusin A showed antitumor effects via autophagy activation and apoptosis induction of colorectal cancer cells.Physical and Pharmacokinetic Characterizations of trans-Resveratrol (t-Rev) Encapsulated with Self-Assembling Lecithin-based Mixed Polymeric Micelles (saLMPMs)Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles.iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes.Potential Anticancer Mechanisms of a Novel EGFR/DNA-Targeting Combi-Molecule (JDF12) against DU145 Prostate Cancer Cells: An iTRAQ-Based Proteomic Analysis.M30/M65 ratio predicts the outcome of paclitaxel chemotherapy for NSCLC.Reversal of drug resistance by planetary ball milled (PBM) nanoparticle loaded with resveratrol and docetaxel in prostate cancer.Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells.Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma.Drug delivery systems for elemene, its main active ingredient β-elemene, and its derivatives in cancer therapy
P2860
Q38694640-BBB8BFB7-1C1C-445C-9570-10DA054B44FCQ38718506-C9A25869-17AA-45F2-8EFE-B1F79EB6D3AFQ38790891-CE7E2C12-DCC3-47BB-8F9B-A94DAB010CA5Q41057564-803FAE4D-1877-4EB0-9668-3AF86CD34A09Q41093636-993A9F5D-6C86-42BB-B837-D4127874A715Q41629561-AC2CB4E8-C968-4C09-84D3-791CE24F9636Q41694084-655616EB-4506-458B-B2F4-3EF861FC7B5FQ46505275-A30721F7-63B5-446C-A6C8-E993B6043AE5Q47156384-8A3C6D07-09BE-4DB0-8A07-33426CC08614Q51226881-82644338-1688-4A21-97C2-8A5307EC34A2Q52573697-0055CE86-8049-4EC1-B69E-FC7A4E89E62BQ52716704-1C21C7C5-8D65-4894-83F8-AEC5A9951051Q52727607-3B7CDA16-AB15-4AC0-9E3B-EEDE66991012Q57816230-51A535DB-5E57-4F4F-ACAB-431B2F8426FA
P2860
Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Combination Therapy using Co-e ...... in Breast Cancer Cells in vivo
@ast
Combination Therapy using Co-e ...... in Breast Cancer Cells in vivo
@en
type
label
Combination Therapy using Co-e ...... in Breast Cancer Cells in vivo
@ast
Combination Therapy using Co-e ...... in Breast Cancer Cells in vivo
@en
prefLabel
Combination Therapy using Co-e ...... in Breast Cancer Cells in vivo
@ast
Combination Therapy using Co-e ...... in Breast Cancer Cells in vivo
@en
P2093
P2860
P356
P1433
P1476
Combination Therapy using Co-e ...... in Breast Cancer Cells in vivo
@en
P2093
P2860
P2888
P356
10.1038/SREP22390
P407
P577
2016-03-07T00:00:00Z